Pin45 - Cost-Effectiveness of Ceftazidime/Avibactam for the Treatment of Infections Due to Aerobic Gram-Negative Organisms in Patients With Limited Treatment Options
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1364
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV